Dr Camidge and Sofia Diana Merajver, MD, PhD, reflected her lifelong journey shaped by immigration, intellectual curiosity, and a commitment to science in service of human health.
Sofia Diana Merajver, MD, PhD
Advertisement
Sofia Diana Merajver MD, PhD is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center.
Articles by Sofia Diana Merajver, MD, PhD
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer
2
Exploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance
3
FDA Grants Accelerated Approval to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy
4
The OncFive: Top Oncology Articles for the Week of 8/2
5